Skip to main content

Table 3 Differences between corticosteroid and immunosuppressive therapy use between rheumatological and dermatological centers of the DNSS

From: High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

Treatment Rheumatological centers (%) Dermatological centers (%) P value
Corticosteroids 48.3 (360/746) 33.4 (217/650) <0.0001
Immunosuppressants 45.6 (340/745) 24.5 (159/649) <0.0001
Cyclophosphamide 21.5 (73/340) 23.9 (38/159)  
Azathioprine 21.8 (74/340) 22.0 (35/159)  
Methotrexate 35.9 (122/340) 18.9 (30/159) <0.0001
(Hydroxy)chloroquine 8.8 (30/340) 3.8 (6/159) <0.04
  1. DNSS, Deutsches Netzwerk für Systemische Sklerodermie (German Network for Systemic Scleroderma).